FDA Inspection 904003 — Abon Biopharm (Hangzhou) Co., Ltd.
The FDA completed an inspection of Abon Biopharm (Hangzhou) Co., Ltd. on Nov 13, 2014 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 13, 2014
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hangzhou (China)